PT376 – Sherry Rais – Ketamine and Psychedelic-Assisted Therapy as Employee Benefits
Dec 6, 2022
auto_awesome
Sherry Rais, CEO/Co-Founder of Enthea, discusses offering psychedelic therapy through employer health plans, personal anecdotes on running and cultural influences, advocating for mental health equity, expanding access to psychedelic therapy services, implementing ketamine-assisted therapy for employers, and the global deployment of psychedelic medicines.
Employers are recognizing the ROI of offering psychedelic therapy benefits, boosting productivity and talent retention.
Enthia focuses on creating a trusted provider network for quality psychedelic-assisted therapy care.
Companies like Dr. Bronner's are normalizing mental health discussions through ketamine-assisted therapy benefits for employees.
Deep dives
Enthia: Making Psychedelic Therapy Accessible and Affordable
Enthia aims to provide safe and affordable access to psychedelic assisted therapy by creating insurance benefit plans for employers. Their goal is to make these therapies more accessible to those who can benefit from them, offering coverage for treatments like ketamine and eventually MDMA therapy. Enthia focuses on building a trusted provider network and treating providers fairly to ensure quality care. With a mission to reach 100,000 covered lives by the end of 2023 and expanding to 40 cities, Enthia's model addresses the equity crisis in mental health care.
Employer Interest in Psychedelic Therapy Benefits
Employers are increasingly interested in offering psychedelic therapy benefits due to improved employee productivity, reduced absenteeism, and talent retention. Studies show that untreated depression can lead to a 35% decrease in productivity, while mental health challenges have prompted many millennials and Gen Zers to leave their jobs. Employers are seeing the potential return on investment, with data suggesting a $4 return for every dollar invested in mental health for employees. Additionally, offering psychedelic therapy benefits can attract new talent and enhance overall employee well-being.
Provider Credentialing and Enrollment Process at Enthia
Enthia's credentialing process for providers includes verifying licensing, malpractice history, liability coverage, training, and background checks. They bring on medical practitioners, psychiatrists, psychologists, social workers, counselors, and other specialists who can offer the full suite of psychedelic-assisted therapy services. Providers undergo a thorough credentialing process that typically takes about 30 days. Enthia aims to ensure quality care by establishing a trusted network of providers who meet their criteria.
Impact of Ketamine-Assisted Therapy in Normalizing Mental Health Conversations
The podcast discusses how companies like Dr. Bronner's are embracing ketamine-assisted therapy to promote mental health conversations among employees. By sharing personal experiences and offering therapy benefits, these companies are normalizing discussions around mental health, breaking down barriers, and paving the way for open dialogues in workplace settings.
Expansion and Funding of Enthia's Psychedelic Therapy Services
Enthia's journey from version 1.0 to a public benefit corporation, fueled by investor funding, showcases the growth and impact of their psychedelic therapy services. With a successful seed round of $2 million led by Tabula Rasa and other investors, Enthia aims to expand to 40 cities, impacting over 100,000 individuals within a year. This funding enables the company to make psychedelic therapy more accessible and advance the conversation around healing with psychedelics.
In this episode, David interviews Sherry Rais: CEO/Co-Founder of Enthea, a benefit plan administrator offering psychedelic-assisted therapy as a benefit to interested employers.
www.psychedelicstoday.com
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
